Motilal Oswal Nifty MidSmall Healthcare Index Fund
Direct · Growth ₹12.31
06 Jul 2026
NAV
8.5%
Weighted CAGR
?
Weighted Mean CAGR
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
0.33
Sharpe
-17.5%
Max Drawdown
?
Max Drawdown
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
NA
TER
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹12.46 L | 9.1% | -10.8% | 33.0% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | NIFTY 50 | Category avg | Fund edge |
|---|---|---|---|---|
| 1 Year | 9.1% | 14.5% | 9.1% | -5.4% |
| Duration | Mean | Median | Min | Max | Sharpe | Sortino | % Positive | Cat. Mean | Cat. Median |
|---|---|---|---|---|---|---|---|---|---|
| 1 Year | 8.5% | 9.6% | -2.1% | 19.1% | 0.33 | 0.61 | 88% | — | — |
-17.5%
Max Drawdown
2 mo
Drawdown Duration
5 mo
Recovery Time
-5.3%
Avg Drawdown
Calmar Ratio by Duration
0.49
1Y
Compared against NIFTY 50
| Duration | Alpha | Beta | Upside Capture | Downside Capture | Fund CAGR | Bench CAGR |
|---|---|---|---|---|---|---|
| 1 Year | +13.80 | 0.66 | 73.4% | 53.6% | 13.8% | -3.4% |
| 3 Years | +5.08 | 0.72 | 81.7% | 65.3% | 6.9% | 0.1% |
| 5 Years | +2.27 | 0.72 | 81.7% | 65.3% | 4.1% | 0.0% |
| 7 Years | +1.09 | 0.72 | 81.7% | 65.3% | 2.9% | 0.0% |
| 10 Years | +0.22 | 0.72 | 81.7% | 65.3% | 2.0% | 0.0% |
| 12 Years | -0.12 | 0.72 | 81.7% | 65.3% | 1.7% | 0.0% |
| 15 Years | -0.46 | 0.72 | 81.7% | 65.3% | 1.3% | 0.0% |
29
Total Holdings
61.5%
Top 10 Weight
3
Sectors
| # | Stock | % of NAV |
|---|---|---|
| 1 | Lupin Ltd | 10.67% |
| 2 | Fortis Healthcare Ltd | 7.87% |
| 3 | Laurus Labs Limited | 7.34% |
| 4 | Aurobindo Pharma Ltd | 6.93% |
| 5 | Glenmark Pharmaceuticals Ltd | 6.10% |
| 6 | Alkem Laboratories Limited | 5.89% |
| 7 | Biocon Ltd | 4.90% |
| 8 | Mankind Pharma Limited | 4.31% |
| 9 | IPCA Laboratories Ltd | 4.23% |
| 10 | Aster DM Healthcare Limited | 3.22% |